Tango Therapeutics, Inc.
Developing precision oncology therapies for genetically-defined patients via synthetic lethality.
TNGX | US
Overview
Corporate Details
- ISIN(s):
- US87583X1090
- LEI:
- Country:
- United States of America
- Address:
- 201 BROOKLINE AVENUE, 2215 BOSTON
- Website:
- https://www.tangotx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of a new generation of precision oncology medicines. The company leverages the principle of synthetic lethality to develop therapies that take direct aim at specific tumors within genetically defined patient populations. Utilizing a proprietary drug discovery platform that is based on CRISPR technology, Tango identifies novel drug targets to create transformative treatments for cancers with high unmet medical needs. The company's patient-centric approach aims to expand the reach and effectiveness of genetically targeted therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tango Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tango Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tango Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
